Sun Pharma, Dr Reddy’s, Glenmark launch generic semaglutide injection in India

NEW DELHI: (Mar 21) Indian pharma majors Sun Pharma, Dr Reddy’s and Glenmark on Saturday announced the launch of their generic versions of semaglutide injection used for diabetes and weight management following the molecule behind products like Ozempic and Wegovy going off patent in India.

The prices of the generic versions of semaglutide injection are considerably lower than the prices of the innovator, Novo Nordisk.

Sun Pharmaceutical Industries launched its semaglutide injection under the brand names Noveltreat and Sematrinity in India, in all strengths.

Source: PTI News

Digitalmitra